Brauer

Main information

Documents

Localization

  • Available in:
  • Brauer Kids Manuka Honey Chesty Cough
    Australia
  • Language:
  • English

Other information

Status

  • Source:
  • Dept. of Health,Therapeutic Goods Administration - Australia
  • Authorization number:
  • 222225
  • Last update:
  • 08-10-2017

Public Assessment Report

Public Summary

Summary for ARTG Entry:

222225

Brauer Kids Manuka Honey Chesty Cough

ARTG entry for

Medicine Listed

Sponsor

Brauer Natural Medicine Pty Ltd

Postal Address

PO Box 234,TANUNDA, SA, 5352

Australia

ARTG Start Date

9/04/2014

Product category

Medicine

Status

Active

Approval area

Listed Medicines

Conditions

Colouring agents used in listed medicine for ingestion, other than those listed for export only under section 25 of the Act, shall be only those included in

the list of 'Colourings permitted in medicines for oral use'.

The sponsor shall keep records relating to this listed medicine as are necessary to: (a) Expedite recall if necessary of any batch of the listed medicine,

(b) Identify the manufacturer(s) of each batch of the listed medicine. Where any part of or step in manufacture in Australia of the listed medicine is

sub-contracted to a third party who is not the sponsor, copies of relevant Good Manufacturing Practice agreements relation to such manufacture shall be

kept.

The sponsor shall retain records of the distribution of the listed medicine for a period of five years and shall provide the records or copies of the records

to the Complementary Medicines Branch, Therapeutic Goods Administration, upon request.

The sponsor of the listed medicine must not, by any means, intentionally or recklessly advertise the medicine for an indication other than those accepted

in relation to the inclusion of the medicine in the Register.

All reports of adverse reactions or similar experiences associated with the use or administration of the listed medicine shall be notified to the Head, Office

of Product Review, Therapeutic Goods Administration, as soon as practicable after the sponsor of the goods becomes aware of those reports. Sponsors

of listed medicines must retain records of such reports for a period of not less than 18 months from the day the Head, Office of Product Review is notified

of the report or reports.

The sponsor shall not supply the listed medicine after the expiry date of the goods.

Where a listed medicine is distributed overseas as well as in Australia, product recall or any other regulatory action taken in relation to the medicine

outside Australia which has or may have relevance to the quality, safety or efficacy of the goods distributed in Australia, must be notified to the National

Manager Therapeutic Goods Administration, immediately the action or information is known to the sponsor.

Products

1. Brauer Kids Manuka Honey Chesty Cough

Product Type

Single Medicine Product

Effective date

9/04/2014

Warnings

Adults only. OR Not to be used in children under two years of age without medical advice (or words to that effect).

If coughing persists consult your doctor (or a healthcare professional) (or words to that effect).

If symptoms persist consult your healthcare practitioner (or words to that effect).

Contains ethanol. (or words to that effect).

Contains homoeopathic ingredients.

(If medicine contains one hydroxybenzoate) Contains [insert name of hydroxybenzoate] OR (If medicine contains two or more hydroxybenzoates)

Contains hydroxybenzoates [or words to that effect].

(If medicine contains one sugar) contains [insert name of sugar] OR (If medicine contains two or more sugars) Contains sugars [or words to that effect].

Not suitable for infants under the age of twelve months (or words to that effect).

Standard Indications

Temporary relief of cough due to bronchial congestion. [Warnings COU1 and COU2 required]

Specific Indications

Temporary relief of chesty mucous coughs.

Additional Product information

Pack Size/Poison information

Pack Size

Poison Schedule

Components

1. Formulation 1

Dosage Form

Oral Liquid

Route of Administration

Oral

Public Summary

Page 1 of

Produced at 26.11.2017 at 11:51:34 AEDT

This is not an ARTG Certificate document.

The onus is on the reader to verify the current accuracy of the information on the document subsequent to the date shown.

Visit www.tga.gov.au for contact information

Visual Identification

Active Ingredients

Anemone pulsatilla (Homeopathic)

5 microlitre/mL

antimony potassium tartrate trihydrate (Homeopathic)

5 microlitre/mL

Hedera helix

36 microlitre/mL

Equivalent: Hedera helix (Dry)

18 mg/mL

Honey

65 mg/mL

Honey

325 mg/mL

phosphorus (Homeopathic)

5 microlitre/mL

Thymus vulgaris MIS

16 microlitre/mL

Equivalent: Thymus vulgaris MIS (Dry)

16 mg/mL

Tin (Homeopathic)

5 microlitre/mL

© Commonwealth of Australia.This work is copyright.You are not permitted to re-transmit, distribute or commercialise the material without obtaining prior

written approval from the Commonwealth.Further details can be found at http://www.tga.gov.au/about/website-copyright.htm.

Public Summary

Page 2 of

Produced at 26.11.2017 at 11:51:34 AEDT

This is not an ARTG Certificate document.

The onus is on the reader to verify the current accuracy of the information on the document subsequent to the date shown.

Visit www.tga.gov.au for contact information

There are no safety alerts related to this product.

1-8-2018

Champix (Pfizer Europe MA EEIG)

Champix (Pfizer Europe MA EEIG)

Champix (Active substance: varenicline tartrate) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018)5197 of Wed, 01 Aug 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/699/T/71

Europe -DG Health and Food Safety

28-5-2018

Procysbi (Chiesi Farmaceutici S.p.A.)

Procysbi (Chiesi Farmaceutici S.p.A.)

Procysbi (Active substance: mercaptamine (cysteamine bitartrate)) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018)3337 of Mon, 28 May 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/2465/T/21

Europe -DG Health and Food Safety